E-ISSN 2651-3455 (Online) | ISSN 2630-5593 (Print)
Side Effects of Long-Term Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease [anatol j fm]
anatol j fm. 2024; 7(3): 115-120 | DOI: 10.5505/ajfamed.2024.43531

Side Effects of Long-Term Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease

Fatma Ceren Gürel1, Deniz Bilici2, Esra Ertan Yazar2, Burcu Arpinar Yigitbas2, Coşkun Doğan2, Hacer Hicran Mutlu1, Mehmet Sargın1
1Department of Family Medicine, Istanbul Medeniyet University, Faculty of Medicine, İstanbul, Türkiye
2Department of Chest Diseases, Istanbul Medeniyet University, Faculty of Medicine, İstanbul, Türkiye

INTRODUCTION: The literature lacks sufficient data on the long-term side effects of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) when used for over a year. In this study, the frequency of potential side effects was investigated in patients with COPD who had been using ICS.
METHODS: This single-center and observational study included stable COPD patients diagnosed with spirom-etry who had been using ICS for at least 1 year. Patient demographic and clinical characteristics and ICS-related side effects were recorded in detail according to the hospital records.
RESULTS: The study enrolled 92 patients, 74 (80.4%) of whom were male, with an mean age of 66.5±8.4 years. The frequency of potential side effects of ICS, including voice changes, oral candidiasis, bruises, and cataracts, was higher after treatment than before treatment (3 [3.3%] vs. 34 [36.9%], p<0.001; 3 [3.3%] vs. 15 [16.0%], p=0.008; 2 [2.2%] vs. 14 [15.2%], p=0.004; and 9 [9.8%] vs. 25 [27.2%], p=0.009, respectively). However, there was no difference in the frequency of adverse events such as pneumonia, mycobacterial infection, osteoporo-sis, and diabetes mellitus before and after treatment (20 [21.7%] vs. 19 [20.7%], p=0.860; 8 [8.7%] vs. 2 [2.2%], p=0.109; 4 [4.3%] vs. 8 [8.7%], p=0.388; and 10 [10.9%] vs. 13 [14.1%], p=0.678, respectively).
DISCUSSION AND CONCLUSION: Recognizing and assessing the side effects of ICS in patients with COPD and evaluating decisions regarding the use of ICS in routine clinical practice based on the benefit-risk ratio may be necessary.

Keywords: Adverse effects, cataract, chronic obstructive pulmonary disease, oral candidiasis, pneumonia

Corresponding Author: Deniz Bilici, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE
LookUs & Online Makale